IBDEI1QO ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29507,0)
 ;;=N85.2^^115^1467^13
 ;;^UTILITY(U,$J,358.3,29507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29507,1,3,0)
 ;;=3^Enlarged Uterus
 ;;^UTILITY(U,$J,358.3,29507,1,4,0)
 ;;=4^N85.2
 ;;^UTILITY(U,$J,358.3,29507,2)
 ;;=^270521
 ;;^UTILITY(U,$J,358.3,29508,0)
 ;;=D25.9^^115^1467^14
 ;;^UTILITY(U,$J,358.3,29508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29508,1,3,0)
 ;;=3^Fibroid Uterus
 ;;^UTILITY(U,$J,358.3,29508,1,4,0)
 ;;=4^D25.9
 ;;^UTILITY(U,$J,358.3,29508,2)
 ;;=^5002081
 ;;^UTILITY(U,$J,358.3,29509,0)
 ;;=Z85.42^^115^1467^15
 ;;^UTILITY(U,$J,358.3,29509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29509,1,3,0)
 ;;=3^Hx of Uterine Cancer
 ;;^UTILITY(U,$J,358.3,29509,1,4,0)
 ;;=4^Z85.42
 ;;^UTILITY(U,$J,358.3,29509,2)
 ;;=^5063419
 ;;^UTILITY(U,$J,358.3,29510,0)
 ;;=N81.2^^115^1467^16
 ;;^UTILITY(U,$J,358.3,29510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29510,1,3,0)
 ;;=3^Incomplete Uterovaginal Prolapse
 ;;^UTILITY(U,$J,358.3,29510,1,4,0)
 ;;=4^N81.2
 ;;^UTILITY(U,$J,358.3,29510,2)
 ;;=^5015839
 ;;^UTILITY(U,$J,358.3,29511,0)
 ;;=N85.01^^115^1467^11
 ;;^UTILITY(U,$J,358.3,29511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29511,1,3,0)
 ;;=3^Endomet Hyperpla w/o Atyp
 ;;^UTILITY(U,$J,358.3,29511,1,4,0)
 ;;=4^N85.01
 ;;^UTILITY(U,$J,358.3,29511,2)
 ;;=^338264
 ;;^UTILITY(U,$J,358.3,29512,0)
 ;;=D25.0^^115^1467^17
 ;;^UTILITY(U,$J,358.3,29512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29512,1,3,0)
 ;;=3^Submucous Fibroid
 ;;^UTILITY(U,$J,358.3,29512,1,4,0)
 ;;=4^D25.0
 ;;^UTILITY(U,$J,358.3,29512,2)
 ;;=^267640
 ;;^UTILITY(U,$J,358.3,29513,0)
 ;;=N93.9^^115^1467^18
 ;;^UTILITY(U,$J,358.3,29513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29513,1,3,0)
 ;;=3^Uterine Bleeding
 ;;^UTILITY(U,$J,358.3,29513,1,4,0)
 ;;=4^N93.9
 ;;^UTILITY(U,$J,358.3,29513,2)
 ;;=^5015916
 ;;^UTILITY(U,$J,358.3,29514,0)
 ;;=N85.4^^115^1467^19
 ;;^UTILITY(U,$J,358.3,29514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29514,1,3,0)
 ;;=3^Uterine Malposition
 ;;^UTILITY(U,$J,358.3,29514,1,4,0)
 ;;=4^N85.4
 ;;^UTILITY(U,$J,358.3,29514,2)
 ;;=^270525
 ;;^UTILITY(U,$J,358.3,29515,0)
 ;;=N84.0^^115^1467^20
 ;;^UTILITY(U,$J,358.3,29515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29515,1,3,0)
 ;;=3^Uterine Polyps
 ;;^UTILITY(U,$J,358.3,29515,1,4,0)
 ;;=4^N84.0
 ;;^UTILITY(U,$J,358.3,29515,2)
 ;;=^270517
 ;;^UTILITY(U,$J,358.3,29516,0)
 ;;=N81.4^^115^1467^21
 ;;^UTILITY(U,$J,358.3,29516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29516,1,3,0)
 ;;=3^Uterovaginal Prolapse,Unspec
 ;;^UTILITY(U,$J,358.3,29516,1,4,0)
 ;;=4^N81.4
 ;;^UTILITY(U,$J,358.3,29516,2)
 ;;=^5015841
 ;;^UTILITY(U,$J,358.3,29517,0)
 ;;=O02.0^^115^1468^1
 ;;^UTILITY(U,$J,358.3,29517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29517,1,3,0)
 ;;=3^Blighted Ovum
 ;;^UTILITY(U,$J,358.3,29517,1,4,0)
 ;;=4^O02.0
 ;;^UTILITY(U,$J,358.3,29517,2)
 ;;=^5015978
 ;;^UTILITY(U,$J,358.3,29518,0)
 ;;=O03.9^^115^1468^2
 ;;^UTILITY(U,$J,358.3,29518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29518,1,3,0)
 ;;=3^Complete SAB
 ;;^UTILITY(U,$J,358.3,29518,1,4,0)
 ;;=4^O03.9
 ;;^UTILITY(U,$J,358.3,29518,2)
 ;;=^5016007
 ;;^UTILITY(U,$J,358.3,29519,0)
 ;;=O00.9^^115^1468^3
 ;;^UTILITY(U,$J,358.3,29519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29519,1,3,0)
 ;;=3^Ectopic Pregnancy
 ;;^UTILITY(U,$J,358.3,29519,1,4,0)
 ;;=4^O00.9
 ;;^UTILITY(U,$J,358.3,29519,2)
 ;;=^97812
 ;;^UTILITY(U,$J,358.3,29520,0)
 ;;=O01.9^^115^1468^4
 ;;^UTILITY(U,$J,358.3,29520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29520,1,3,0)
 ;;=3^Hydatidiform Mole,Unspec
 ;;^UTILITY(U,$J,358.3,29520,1,4,0)
 ;;=4^O01.9
